一个新的基于心磁共振的个性化风险分层模型在扩张性心肌病:一个前性研究
Di Zhou1, Leyi Zhu1, Weichun Wu2
1Department of Magnetic Resonance Imaging, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Road, Beijing, 100037, China.
European radiology
|November 10, 2023
概括
心脏磁共振 (CMR) 度量,如细胞外体积 (ECV) 分数,可以预测扩张性心肌病 (DCM) 的中期结果. 使用CMR生物标志物的新风险算法改善了患者风险分层和临床决策.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
- 生物标志物 生物标志物
背景情况:
- 扩张性心肌病 (DCM) 是心力衰竭和心脏突然死亡的重要原因.
- 准确的风险分层对于管理DCM患者和指导治疗决策至关重要.
研究的目的:
- 评估个人心磁共振 (CMR) 度量对DCM患者中期结果的预测值.
- 使用CMR衍生生物标志物开发用于DCM预后的新风险算法.
主要方法:
- 预计将有407名DCM患者接受CMR成像检查.
- 主要终点:心力衰竭死亡,突然心脏死亡 (SCD),堕胎的SCD和心脏移植的复合.
- 分析CMR指标,包括左心室喷射分数 (LVEF),晚期加多增强 (LGE) 和细胞外体积 (ECV) 分数.
主要成果:
- 中期随访 (中位数为21.7个月) 显示了63个主要终点事件.
- 脑电静脉分数≥32.8% (HR=5.922,p<0.001) 和LGE>6.6% (HR=6.028,p=0.003) 是不良结果的强有力的预测因素.
- ECV 分数成为最强的独立预测指标,超过LVEF和LGE的总体中期结果.
结论:
- ECV 分数是DCM中期结果的强大独立预测指标,其表现优于LVEF和LGE.
- 对于SCD和堕胎的SCD,LGE显示出显著的预后价值.
- 一个基于CMR的新型风险算法,包括ECV,LGE,LVEF和NYHA类,为DCM的个性化风险评估和临床决策提供了一个有前途的工具.
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:25Cardiomyopathy I: Introduction and Classification
14
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15